While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Contrary to ideas that diet culture has embedded in our collective subconscious, Ozempic and the expanding class of drugs known as GLP-1 receptor agonists (or GLP-1s) offer further evidence that ...

NotCo announced Thursday the launch of its GLP Booster, a product that can be mixed into any food to naturally help you feel ...

Ozempic's dramatic weight loss results come with an unexpected complication - hair thinning. Learn why it happens, who's at ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at ...

PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...

Two new class action complaints, both captioned Robins v. Lemme Inc., were filed in in California Superior Court and the Southern District of New ...

These patients were compared to a control group of 206,005 with no history of Ozempic use. The cohorts were analyzed to determine the relationship between the time elapsed from their last Ozempic ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...